Abstract
Introduction
The pandemic AIDS (acquired immunodeficiency syndrome) disease has killed more than 36 million people, and the number of the HIV infected patients exceeds 39 inhibitor (NNRTI), was first isolated from a Malaysian plant Callophylum lanigerum (Kashman et al., 1992) . It has been investigated continuously in clinical trials (ClinicalTrials.gov, 2016a). Betulinic acid is a triterpene, which can be found in many plant species. One of its derivatives (PA457) is currently in Phase II clinical study for the treatment of HIV (ClinicalTrials.gov, 2016b). Ingenol is a diterpenoid isolated from the dried roots of Euphorbia desmondi (Evans and Kinghorn, 1974) . Its triacetate showed potent anti-HIV activity (Fujiwara et al., 1996a and 1996b) . Conocurvone, a trimeric naphthoquinone isolated from an Australian plant Conospermum incurvum Lindley (Decosterd et al., 1993) , is under drug development by an Australian company. Its anti-HIV mechanism of action occurs in the late phase of the viral replication cycle.
In the past 15 years, our medicinal plant research program has evaluated antiviral activity of more replication at a concentration 20 g/mL. The anti-HIV activity of this plant was further confirmed by evaluation of the MeOH extract (SVA5614) made from the subsequently recollected stem and bark materials of the plant species in the same area, which showed that SVA5614 was able to inhibit HIV replication at a low concentration (IC50 0.04 g/mL) without cytotoxicity when tested at much higher concentration of 20 g/mL.
J. gendarussa is a medicinal plant that has been used for the treatment of various diseases in
Asian countries. The plant is a bush of up to about 1.5 m in height, and is found in Southern Asia including China, Vietnam, Thailand, India, Sri Lanka, Pakistan and Indonesia. The whole plant has been used as a native medicinal plant for the treatment of injury from falls and rheumatism in the provinces of China including Guangdong, Guangxi and Taiwan (Jiangsu, 1986 ). The plant is also widely distributed in the other Southern Asia countries, and is being used in these countries for the treatment of fever, hemiplegia, arthritis, headache, respiratory disorders, muscle pain and digestive trouble (Kavitha et al., 2014; Paval et al., 2009 ). Bioassay-guided fractionation of the plant extract SVA5614 led to the isolation of two anti-HIV compounds. The compounds, designated as justiprocumins A (1) and B (2) respectively, belong to arylnaphthalide lignan (ANL) glycosides, which are determined to be novel molecules (Fig. 1 ). In addition, we have analyzed the active and non-active fractions of the plant extract using HPLC techniques, and discovered that only the active fractions contained ANL glycosides. The inactive fractions are devoid of these molecules.
The current paper reports the isolation, identification and biological evaluation of the anti-HIV ANL glycoside from the plant J. gendarussa.
Results and discussion
The dried, milled plant material (4.0 kg) was extracted with MeOH to afford a MeOH extract (SVA5614, 155 g). Chromatographic fractionation of SVA5614 over a silica gel column afforded the active fraction F26, which was subjected to preparative HPLC separation to yield 8 fractions (F41-F48). The active fractions F45 and F48 were found to consist of pure compounds, which were given the names of justiprocumins A (1) and B (2) ascribed to an acetyloxy group, which was assigned to C-3 due to the presence of the HMBC correlations of the acetyl methyl protons to C-3. Accordingly, 1 was determined as 9-(1,3- S6 and S13, Supplementary data). In combination of analysis of the 2D NMR data including 1 H-1 H COSY, HMQC and HMBC spectral data, 2 was determined as 9-
c]furan-1(3H)-one, and was given the trivial name justiprocumin B.
The potent anti-HIV ANL glycosides (1 and 2) have been identified from the MeOH extract of J.
gendarussa. We further analyzed the active and non-active fractions of the plant extract using TLC and HPLC-UV techniques (Fig. S15, Supplementary data) . We discovered that only the active fractions contained ANL glycosides, suggesting that the ANL glycosides are the active components responsible for the anti-HIV activity of this plant. An herbal product formulation enriched with ANL glycosides may be amenable to become a theraputic candidate for the treatment of HIV/AIDS disease.
Justiprocumin B (2) was evaluated for its anti-HIV-1 activity against the broadness of the spectrum of HIV strains. Four HIV-1 clinical isolates, BAL and SF162 (both are M-tropic), LAV0.04
(T-tropic), and 89.6 (dual tropic), were tested against compound 2 using a standardized human peripheral blood mononuclear cell culture (PBMC) assay (Japour et al., 1993) . Compound 2 displayed potent inhibition activity against the particle production of all four HIV-1 isolates (Fig. S16 , Supplementary data). It gave the IC50 values ranging from 14 to 21 nM as compared to the IC50 values of 77-95 nM for the clinically used drug AZT (zidovudine) ( Table 2 ).
The compound was further evaluated for its efficacy against the drug-resistant HIV isolates NRTI (nucleoside reverse transcriptase inhibitor)-resistant isolate (HIV-11617-1) and NNRTI (non-nucleoside reverse transcriptase inhibitor)-resistant isolate (HIV-1N119) using the standardized human peripheral blood mononuclear cell culture (PBMC) assay (Japour et al., 1993) . As shown in Table 2 In the present study we report the isolation and structure identification of two new ANL glycosides (1 and 2) from higher plants. Justiprocumin B (2) displayed broad spectrum and potent anti-HIV-1 activity including its anti-HIV activity against NRTI-and NNRTI-resistant HIV-1 variants. The chemical structures of the two compounds were identified as ANL glycosides based on the spectroscopic methods including 1D and 2D NMR spectral data (Fig. 1) . Many resonance signals in the 1 H NMR spectra of the two compounds were split into two, indicating atropisomerism due to the stereo hindrance of the bond rotation between C-1 and C-7 (Fig. S17, Supplementary data) 
Conclusion
Two new anti-HIV lead compounds [justiprocumins A (1) and B (2)] were successfully isolated from the stems and the barks of J. gendarussa using our "One-Stone-Two-Birds" bioassay evaluation guided system. The cell-based evaluation protocol was using the viral entry mediated glycoprotein (GP) 
Experimental

General experimental procedures
Optical rotations were measured with a Perkin-Elmer model 241 polarimeter. IR spectra were recorded on a Jasco FT/IR-410 spectrometer, equipped with a Specac Silver Gate ATR system by applying a film on a Germanium plate (Jasco, Maryland). 1D and 2D NMR spectra were recorded on a 
Plant materials
The initial collection of root and stem sample of Justicia gendarussa Burm. f. 
Extraction and isolation
The dried, milled plant material (4.0 kg) was extracted with methanol to afford 155 g of extract. A small portion of the methanol extract (5.5 g) was rapidly fractionated to 22 fractions (Fa1-Fa22) in one hour over a silica gel (10 g) column eluting with gradient CHCl3, CHCl3/Me2CO, and CHCl3/MeOH solutions. Anti-HIV evaluation of the fractions determined that the fractions Fa14-Fa18 inhibited HIV replication by more than 95 % at a concentration of 0.1 g/mL without apparent toxicity at 20 g/mL. C NMR data, see Table 1 ; positive HRESIMS m/z 731.2216
Scale
Justiprocumin A (1)
[M+H] + (calcd for C35H38O17, 731.2187).
"One-Stone-Two-Birds" anti-HIV evaluation assay
This protocol allows us to identify potential inhibitors for HIV replication (post-entry steps). In this system, the HIV vector pNL4-3. Table 1 1 H (500 MHz) and 13 C (100 MHz) NMR data of compounds 1 and 2 in methanol-d4.
Table 2
Inhibition activity of justiprocumin B (2) against HIV clinical strains and resistant strains. (Color figure is desired for color reproduction on the Web)
